Shaheryar Ansari, MD
Neurological Surgery · Lakewood, CONPI 1659646917
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (38.4%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Arteriocyte Medical Systems, Inc. at 42.1% of the total. Reporting peaked in 2024 at $7,284 and has fallen 91.5% since, to $619 in 2025.
Across 103 payments — averaging $151.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arteriocyte Medical Systems, Inc.$7K
- Medtronic$5K
- Stryker$4K
- Johnson & Johnson$94
- AbbVie$68
- CSL Behring$20
- plus $32 from 2 others
What the payments were for
- Consulting fees$5,52035%
- Speaking & faculty fees$6,00038%
- Travel & lodging$1,3829%
- Food & beverage$2,69517%
- Education$200%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arteriocyte Medical Systems, Inc. | 4 | $6,580 |
| Medtronic(2 entities) | 81 | $5,189 |
| Stryker | 11 | $3,634 |
| Johnson & Johnson | 2 | $94 |
| AbbVie | 2 | $68 |
| CSL Behring | 1 | $20 |
| Biocomposites Inc | 1 | $18 |
| Mallinckrodt Enterprises LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SONOPET IQ$1,467
- CLYDESDALE PTC SPINAL SYSTEM$704
- CORE$700
- O-ARM-ST$580
- O-ARM$580
- NA$450
- PIVOX Oblique Lateral Spinal System$175
- OPTABLATE$169
- SPINEJACK$169
- DIVERGENCE-L ANTERIOR/OBLIQUE LUMBAR FUSION SYSTEM$168
- RIALTO$143
- ANTERALIGN SPINAL SYSTEM WITH TITAN NANOLOCK SURFACE TECHNOLOGY$142
- PRESTIGE$121
- MazorX - Renaissance$110
How this compares
$15,618 in reported general payments places this provider in the 65th percentile of 149 neurological surgery providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 37 | $495 |
| Cyclobenzaprine Hcl | 45 | $390 |
| Gabapentin | 27 | $239 |
| Tizanidine Hcl | 26 | $197 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 13 | $116 |
| Meloxicam | 15 | $62 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Lakewood
- Joshua BeckmanLakewood$42K
- Randall AllisonLakewood$15K
- Sharad RajpalBoulder$2.8M
- Chad PrusmackLone Tree$2.1M
- Timothy WirtFort Collins$581K
- Donn TurnerFort Collins$581K
- Ernest BraxtonEdwards$549K
- Bradley DuhonLone Tree$386K
- Peter SyreEnglewood$301K
- Sean MarkeyDenver$170K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.